DEXAMETHASONE USE IN MANAGEMENT OF COVID19: A REVIEW

DEXAMETHASONE USE IN MANAGEMENT OF COVID19: A REVIEW

The lack of active 2019 coronavirus disease (COVID-19) pandemic treatment creates a challenge for researchers and scientists to find the most appropriate treatment for this disease. Dexamethasone, according to the findings of the RECOVERY clinical trial, declared mid-June 2020 in print media was one...

Full description

Bibliographic Details
Main Author:	Samer Mohammed
Format:	Article
Language:	English
Published:	Education in Action Club 2021-03-01
Series:	Global Journal of Public Health Medicine
Subjects:	covid-19, dexamethasone, acute respiratory distress syndrome, randomized controlled trial, steroids, pandemic.
Online Access:	https://www.gjphm.org/index.php/gjphm/article/view/72

Similar Items

High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial
by: Luis Patricio Maskin, et al.
Published: (2020-08-01)

Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report
by: Jennifer Jacobson, et al.
Published: (2021-01-01)

Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial
by: Jesús Villar, et al.
Published: (2020-08-01)

Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
by: Keivan Ranjbar, et al.
Published: (2021-04-01)

Progression from Pneumonia to ARDS as a Predictor for Fatal COVID-19
by: Chen-Yang Hsu, et al.
Published: (2021-04-01)

Can NLRP3 inhibitors improve on dexamethasone for the treatment of COVID-19?
by: Alexander Hooftman, et al.
Published: (2021-01-01)

Covid-19-related vs Covid-19-unrelated Acute respiratory distress syndrome - key differences
by: Harish Mallapura Maheshwarappa, et al.
Published: (2021-01-01)

Hemodialysis in COVID-19 Patients: Yes or No? A Commentary
by: Amin Hosseini, et al.
Published: (2020-07-01)

Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort
by: Pedro David Wendel Garcia, et al.
Published: (2020-08-01)

Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in north India
by: Shiv Lal Soni, et al.
Published: (2021-01-01)

Effects of Steroids and Tocilizumab on the Immune Response Profile of Patients with COVID-19-Associated ARDS Requiring or Not Veno-Venous Extracorporeal Membrane Oxygenation
by: Vito Fanelli, et al.
Published: (2021-08-01)

Dexamethasone fails to improve bleomycin‐induced acute lung injury in mice
by: Mélissa Aubin Vega, et al.
Published: (2019-11-01)

Case Report: Survival of A Coronavirus Disease-2019 (Covid-19) Patient with Acute Respiratory Distress Syndrome (ARDS) in Dr. Soetomo Hospital, Surabaya, Indonesia
by: Soedarsono Soedarsono, et al.
Published: (2021-01-01)

Masi: A mechanical ventilator based on a manual resuscitator with telemedicine capabilities for patients with ARDS during the COVID-19 crisis
by: Javier Chang, et al.
Published: (2021-04-01)

A nomogram for predicting acute respiratory distress syndrome in COVID-19 patients
by: Ning Ding, et al.
Published: (2021-01-01)

Drug repurposing clinical trials in the search for life-saving COVID-19 therapies; research targets and methodological and ethical issues
by: Francisco José Roma Paumgartten, et al.
Published: (2020-10-01)

Drug repurposing clinical trials in the search for life-saving COVID-19 therapies; research targets and methodological and ethical issues
by: Francisco JosÃ© Roma Paumgartten, et al.
Published: (2020-05-01)

Drug repurposing clinical trials in the search for life-saving COVID-19 therapies; research targets and methodological and ethical issues
by: Francisco José Roma Paumgartten, et al.
Published: (2020-05-01)

Drug repurposing clinical trials in the search for life-saving COVID-19 therapies; research targets and methodological and ethical issues
by: Francisco José Roma Paumgartten, et al.
Published: (2020-05-01)

Co-infection with Influenza A and COVID-19
by: Venu Madhav Konala, et al.
Published: (2020-04-01)

Epidemiology of Coronavirus Disease (COVID-19) in Nigeria
by: JO Bamidele, et al.
Published: (2020-05-01)

Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial
by: Concepción Payares-Herrera, et al.
Published: (2021-01-01)

Acute respiratory distress syndrome and pneumothorax in COVID-19 patients
by: Seyed Mohammad Reza Hashemian, et al.
Published: (2021-01-01)

Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes
by: Janine Alessi, et al.
Published: (2020-09-01)

Extracorporeal Hemoperfusion as a Potential Therapeutic Option for Severe COVID-19 patients; a Narrative Review
by: Saeid Safari, et al.
Published: (2020-08-01)

Cryptococcus neoformans blood stream infection in severe COVID-19 pneumonia
by: Rama. V Thyagarajan, et al.
Published: (2021-01-01)

Mesenchymal stem cells: current clinical progress in ARDS and COVID-19
by: Kun Xiao, et al.
Published: (2020-07-01)

COVID-19 biobank: features of the cytokine profile
by: N. N. Sushentseva, et al.
Published: (2020-12-01)

A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review
by: Priyanka Dash, et al.
Published: (2021-02-01)

Dexamethasone for treatment of severe COVID-19, a surprise?
by: Hany Hasan Elsayed
Published: (2020-09-01)

Dexamethasone in the Treatment of COVID-19: Primus Inter Pares?
by: Vasiliki Romanou, et al.
Published: (2021-06-01)

Prolonged of non-invasive ventilation in COVID-19 patient: Intubate or not – A case report
by: Kun Arifi Abbas, et al.
Published: (2021-01-01)

Long-Lasting Cognitive Abnormalities after COVID-19
by: Roberta Ferrucci, et al.
Published: (2021-02-01)

Acute respiratory failure in COVID-19: is it “typical” ARDS?
by: Xu Li, et al.
Published: (2020-05-01)

COVID-19 and pulmonary rehabilitation
by: Aysegul Beykumul, et al.
Published: (2020-01-01)

Pulmonary Surfactant Preparations and Surfactant Therapy for ARDS in Surgical Intensive Care (a Literature Review)
by: O. A. Rosenberg
Published: (2019-04-01)

Tocilizumab for treating severe COVID‐19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series
by: Manoon Surabotsophon, et al.
Published: (2020-12-01)

Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method
by: Prashant Nasa, et al.
Published: (2021-03-01)

Fatal Ischaemic Stroke During COVID-19 and Acute Lung Injury
by: Iris Duroi, et al.
Published: (2020-05-01)

Successful management of COVID-19 induced acute respiratory distress syndrome by extracorporeal membrane oxygenation with 1-year follow-up: A case report
by: Ko-Wei Chang, et al.
Published: (2021-01-01)

Cannot write session to /tmp/vufind_sessions/sess_s6j1cglht8l4qcethhqkst0s94